详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Hybrid lipid-polymer nanoparticles for sustained siRNA delivery and gene silencing.

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]Laboratory of Nanomedicine and Biomaterials, Department of Anesthesiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA [2]Vascular Biology Program, Children’s Hospital Boston, Harvard Medical School, Boston, MA, USA [3]Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA [4]Key Laboratory of Drug Targeting and Drug Delivery System, West China School of Pharmacy, Sichuan University, Chengdu, China [5]King Abdulaziz University, Jeddah, Saudi Arabia

出处：

DOI：

ISSN：

关键词： Lipid–polymer nanoparticle siRNA Sustained release Gene silencing Cancer

摘要：

The development of controlled-release nanoparticle (NP) technologies has great potential to further improve the therapeutic efficacy of RNA interference (RNAi), by prolonging the release of small interfering RNA (siRNA) for sustained, long-term gene silencing. Herein, we present an NP platform with sustained siRNA-release properties, which can be self-assembled using biodegradable and biocompatible polymers and lipids. The hybrid lipid-polymer NPs showed excellent silencing efficacy, and the temporal release of siRNA from the NPs continued for over one month. When tested on luciferase-expressed HeLa cells and A549 lung carcinoma cells after short-term transfection, the siRNA NPs showed greater sustained silencing activity than lipofectamine 2000-siRNA complexes. More importantly, the NP-mediated sustained silencing of prohibitin 1 (PHB1) generates more effective tumor cell growth inhibition in vitro and in vivo than the lipofectamine complexes. We expect that this sustained-release siRNA NP platform could be of interest in both fundamental biological studies and clinical applications. Emerging gene silencing applications could be greatly enhanced by prolonging the release of siRNA for sustained gene silencing. This team of scientists presents a hybrid lipid-polymer nanoparticle platform that successfully accomplishes this goal, paving the way to future research studies and potential clinical applications. Copyright © 2014 Elsevier Inc. All rights reserved.

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2014]版：

大类 | 1 区

工程技术

小类 | 2 区医学：研究与实验 2 区纳米科技

最新[2023]版：

大类 | 2 区医学

小类 | 3 区医学：研究与实验 3 区纳米科技

第一作者：

第一作者机构： [1]Laboratory of Nanomedicine and Biomaterials, Department of Anesthesiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

共同第一作者：

通讯作者：

通讯机构： [1]Laboratory of Nanomedicine and Biomaterials, Department of Anesthesiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA [5]King Abdulaziz University, Jeddah, Saudi Arabia

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]甲硝唑缓释棒释放度的研究 [2]盐酸羟考酮缓释片与盐酸吗啡缓释片治疗中度癌痛回顾性分析 [3]Rapid titration with oral sustained-release morphine plus subcutaneous morphine in a multi-center, randomized control study of cancer patients with moderate to severe cancer pain [4]5-氟尿嘧啶缓释剂区域植入化疗在中期胃癌治疗中的应用 [5]植入瘤体内的氟尿嘧啶微球 [6]Sustained release of hepatocyte growth factor by cationic self-assembling peptide/heparin hybrid hydrogel improves β-cell survival and function through modulating inflammatory response. [7]Effects of CXCR4 gene silencing by lentivirus shRNA on metastatic characteristics of EC9706 human esophageal carcinoma cell line [8]顺铂泡囊的研制与抗癌活性研究 [9]Preparation, characterization and anticancer therapeutic efficacy of cisplatin-loaded niosomes [10]ICAM3 mediates inflammatory signaling to promote cancer cell stemness.